175965-01-2

Basic information

• Product Name: 1-amino-4,6-dimethylpyridin-2(1H)-iminium-2,4,6-trimethyl-benzenesulfonate
• Synonyms: 1-amino-4,6-dimethylpyridin-2(1H)-iminium-2,4,6-trimethyl-benzenesulfonate
• CAS NO: 175965-01-2
• Molecular Weight: 337.443
• Mol File: 175965-01-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-amino-4,6-dimethylpyridin-2(1H)-iminium-2,4,6-trimethyl-benzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-amino-4,6-dimethylpyridin-2(1H)-iminium-2,4,6-trimethyl-benzenesulfonate(175965-01-2)
• EPA Substance Registry System: 1-amino-4,6-dimethylpyridin-2(1H)-iminium-2,4,6-trimethyl-benzenesulfonate(175965-01-2)

Safety Data

• Hazardous Substances Data: 175965-01-2(Hazardous Substances Data)

Upstream product

• 5407-87-4 2-Amino-4,6-dimethylpyridine 
• 36016-40-7 mesitylenesulfonylhydroxylamine 
• 38202-27-6 ethyl O-(2-mesitylenesulfonyl)acetohydroxamate 

Relevant articles and documents

NOVEL PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS

This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective, amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I).